Calumet, Inc.
NASDAQ:CLMTOil & Gas Exploration & Production
-$1.21 today
- Market cap
- $2.67B
- Beta
- 0.72
- P/E (TTM)
- -14.7
- EPS (TTM)
- -$2.17
Volume 1.74M
Average 1.11M
CLMT Cash & Equivalents
Cash on hand and highly liquid investments that can be converted to cash almost immediately.
Calumet, Inc.NASDAQ: CLMT
Cash & Equivalents · Q3 FY2026 · quarter ended Sep 2026
Cash & equivalents rises 138.1% from a year ago
Cash & equivalents stood at $225.2M at the end of Q3 FY2026, up 138.1% from a year earlier and up 105.1% from the prior quarter. Over 3 fiscal years it compounded at +52.6% a year.
Context
- Cash & equivalents amounted to 7.5% of total assets at the end of Q3 FY2026, up 4.1 pp from a year earlier.
- Cash & equivalents increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether cash & equivalents keeps rising in the next quarterly balance sheet after a +138.1% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Cash & Equivalents history
USD · from the balance sheet
- Latest · FY2025
- 125.1M USD
- Year-over-year change
- +228.3%
- 4-year CAGR
- +34.6%
| Period | Period end | Cash & Equivalents | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 125.1M | +228.3% |
| FY2024 | 2024-12-31 | 38.1M | +382.3% |
| FY2023 | 2023-12-31 | 7.9M | -77.6% |
| FY2022 | 2022-12-31 | 35.2M | -7.6% |
| FY2021 | 2021-12-31 | 38.1M | — |
Cash & Equivalents vs competitors
How CLMT compares with its peers on the latest reported figures
- CLMT's Sep 2026 cash & equivalents of $225.2M is the 5th highest of the 11 companies compared; the peer median is $153.89M.
- Its year-over-year change of +138.1% is the highest of 11, against a peer median of +3.5%.
- Cash & equivalents amounts to 7.5% of total assets for CLMT, versus a peer median of 5.9%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Jun 2026 | $671M | +33.7% | -15.2% | 9.4% | |
| Aug 2026 | $312.84M | +5.3% | +13.5% | 3.8% | |
| Jun 2026 | $250.2M | -6.2% | +25.7% | 13.6% | |
| Jun 2026 | $250M | +4.6% | +7.8% | 6.3% | |
| Sep 2026 | $225.2M | +138.1% | +52.6% | 7.5% | |
| Sep 2026 | $167.01M | -2.9% | -0.2% | 5.7% | |
| Mar 2026 | $140.78M | +31.0% | -8.6% | 6.0% | |
| Jun 2026 | $93.6M | +33.2% | +4.1% | 2.6% | |
| Sep 2026 | $85.4M | +2.4% | +0.6% | 5.7% | |
| Jun 2026 | $82.78M | -41.2% | +37.0% | 2.6% | |
| Mar 2026 | $22.37M | -77.0% | -33.6% | 12.5% | |
| Peer median (excluding CLMT) | $153.89M | +3.5% | +2.4% | 5.9% | |
Competitors are the stored peer set for CLMT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 38.1M | 35.2M | 7.9M | 38.1M | 125.1M |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 |
| Net Receivables | 253M | 267.1M | 286.2M | 278.1M | 232.5M |
| Inventory | 326.6M | 497.7M | 439.4M | 416.3M | 385.2M |
| Other Current Assets | 0 | 19.6M | 54.4M | 33.5M | 115M |
| Total Current Assets | 632.6M | 819.6M | 794.7M | 766M | 857.8M |
| Property, Plant & Equipment (Net) | 1.1B | 1.59B | 1.62B | 1.68B | 1.58B |
| Goodwill | 173M | 173M | 173M | 173M | 140.5M |
| Intangible Assets | 52.6M | 38.4M | 28.5M | 22.8M | 8.7M |
| Long-term Investments | 83.8M | 0 | 0 | 0 | 0 |
| Tax Assets | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Assets | 85.3M | 122.6M | 134.4M | 118.2M | 104.7M |
| Total Non-current Assets | 1.5B | 1.92B | 1.96B | 1.99B | 1.83B |
| Total Assets | 2.13B | 2.74B | 2.75B | 2.76B | 2.69B |
| Account Payables | 301M | 442M | 322M | 320.8M | 281.5M |
| Short-term Debt | 179.6M | 240.5M | 245M | 66.5M | 156.2M |
| Tax Payables | 0 | 0 | 13.5M | 0 | 17.7M |
| Deferred Revenue | 0 | 0 | 190.4M | 0 | 0 |
| Other Current Liabilities | 231.9M | 469.2M | 142.8M | 276.4M | 190.4M |
| Total Current Liabilities | 899.8M | 1.35B | 1.11B | 863.6M | 840.7M |
| Long-term Debt | 1.42B | 1.54B | 1.83B | 2.06B | 2.08B |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 101.3M | 100.6M | 14.6M | 114M | 96.6M |
| Total Non-current Liabilities | 1.61B | 1.68B | 1.88B | 2.36B | 2.34B |
| Total Liabilities | 2.51B | 3.03B | 3B | 3.22B | 3.18B |
| Common Stock | (378.8M) | (525.3M) | (484.4M) | 900K | 900K |
| Retained Earnings | 0 | 0 | 0 | (1.54B) | (1.57B) |
| Accumulated OCI | (10.1M) | (8.3M) | (7.2M) | 800K | (6.8M) |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 846.6M |
| Minority Interest | 3.8M | 245.9M | 246.9M | 246.5M | 245.6M |
| Total Equity | (385.1M) | (287.7M) | (244.7M) | (466.3M) | (487.1M) |
| Total Debt | 1.76B | 1.89B | 2.19B | 2.37B | 2.46B |
| Net Debt | 1.72B | 1.85B | 2.18B | 2.34B | 2.33B |
Calumet, Inc.
NASDAQ:CLMT
Intrinsic Alpha fair value
Locked
Current Price
$30.32
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.